A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
about
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.Metabolism and transport of oxazaphosphorines and the clinical implications.Clinical studies in non-small cell lung cancer: the CALGB experience.Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.
P2860
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A randomized phase II study of ...... er and Leukemia Group B study.
@ast
A randomized phase II study of ...... er and Leukemia Group B study.
@en
type
label
A randomized phase II study of ...... er and Leukemia Group B study.
@ast
A randomized phase II study of ...... er and Leukemia Group B study.
@en
prefLabel
A randomized phase II study of ...... er and Leukemia Group B study.
@ast
A randomized phase II study of ...... er and Leukemia Group B study.
@en
P2093
P1433
P1476
A randomized phase II study of ...... er and Leukemia Group B study.
@en
P2093
Crawford J
Graziano SL
Herndon JE 2nd
Richards F 2nd
P304
P356
10.1016/0169-5002(96)00556-9
P577
1996-06-01T00:00:00Z